We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

BD DIAGNOSTIC SYSTEMS

BD Diagnostics manufactures and markets medical supplies and devices and diagnostic systems that include cellular ana... read more Featured Products: More products

Download Mobile App




Field Performance for Rapid Detection of Influenza Virus Analyzed

By LabMedica International staff writers
Posted on 27 Sep 2016
Print article
Image: The BD Veritor system for rapid detection of Influenza A + B (Photo courtesy of Becton, Dickinson and Company).
Image: The BD Veritor system for rapid detection of Influenza A + B (Photo courtesy of Becton, Dickinson and Company).
Clinical differentiation of influenza A virus from infections caused by influenza B virus and the other viruses is unreliable, however effective antiviral treatment is only available for influenza A virus infections and must be administered early in the course of disease to be effective.

Historically, rapid influenza virus antigen diagnostic tests (RIDTs) were simple to perform but were insensitive, particularly for recently introduced strains of influenza A virus and influenza B virus. In contrast, the more recently introduced digital immunoassays (DIAs) have improved analytical performance.

Microbiologist at Medical Faculty of Istanbul University conducted single-blinded cross sectional study nine different family medicine centers in Istanbul, Turkey between 01 November 2014 and 01 May 2015. Nasopharyngeal specimens were collected by the physicians at the time of the initial patient visit, typically within three days of the onset of symptoms. Two specimens were collected, from each patient: one for real-time polymerase chain reaction RT-PCR and one for the point-of-care (POC) test.

The POC test used was the BD Veritor System for Rapid Detection of Flu A + B (Becton, Dickinson and Company, Franklin Lakes, NJ, USA). It is a rapid digital chromatographic immunoassay for the direct, qualitative detection of influenza A and B viral nucleoprotein antigens from nasal and nasopharyngeal swabs of symptomatic patients and differentiates influenza A and B viral antigens from a processed sample using a single device. The RT-PCR results were reported with the analysis of amplification plot in the Light Cycler 480 II (Roche Diagnostics, Mannheim, Germany).

A total of 122 patients out of 238 were positive for influenza by RT-PCR including 42 with influenza A H1N1, 11 with influenza A H3N2, two with influenza A undetermined strains, and 68 with influenza B. One patient’s PCR test was positive for both influenza A and B but the Veritor test was negative for both viruses. The clinical sensitivity and specificity of the Veritor test in all age groups was determined to be 80% and 94%, respectively. Positive predictive value was 93% and the negative one was 81%.

The authors concluded that the field performance of the rapid influenza test, the BD Veritor System for Rapid Detection of Flu A + B, was high and found to be useful with respect to rational antiviral use, avoiding unnecessary antibiotic usage and the management of cases by the family physicians. The study was published on September 9, 2016, in the journal BMC Infectious Diseases.

Related Links:
Istanbul University
Becton, Dickinson and Company
Roche Diagnostics
Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Reagent Reservoirs
Reagent Reservoirs

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.